Targeting of the immune system in systemic lupus erythematosus.

Expert Reviews in Molecular Medicine
Meera Ramanujam, Anne Davidson

Abstract

Systemic lupus erythematosus (SLE) is a complex immune disorder in which loss of tolerance to nucleic acid antigens and other crossreactive antigens is associated with the development of pathogenic autoantibodies that damage target organs, including the skin, joints, brain and kidney. New drugs based on modulation of the immune system are currently being developed for the treatment of SLE. Many of these new therapies do not globally suppress the immune system but target specific activation pathways relevant to SLE pathogenesis. Immune modulation in SLE is complicated by differences in the immune defects between patients and at different disease stages. Since both deficiency and hyperactivity of the immune system can give rise to SLE, the ultimate goal for SLE therapy is to restore homeostasis without affecting protective immune responses to pathogens. Here we review recent immunological advances that have enhanced our understanding of SLE pathogenesis and discuss how they may lead to the development of new treatment regimens.

References

Jan 1, 1992·Annual Review of Immunology·B DiamondM D Scharff
Jan 28, 1988·Nature·C O Jacob, H O McDevitt
Sep 1, 1987·The Journal of Experimental Medicine·C O JacobH O McDevitt
Jan 1, 1985·Advances in Immunology·A N Theofilopoulos, F J Dixon
Aug 26, 1994·Science·B K FinckD Wofsy
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·E CastigliR S Geha
Aug 1, 1994·The Journal of Clinical Investigation·B K FinckD Wofsy
Jan 1, 1997·Scandinavian Journal of Rheumatology·S LeeS Hirose
Jan 1, 1997·Annual Review of Immunology·T F TedderJ H Kehrl
Feb 7, 1998·The Journal of Clinical Investigation·D BalomenosA N Theofilopoulos
May 23, 1998·Annual Review of Immunology·I S Grewal, R A Flavell
Jul 2, 1998·Clinical and Experimental Immunology·M MiharaY Ohsugi
Nov 25, 1998·Seminars in Immunology·L A Vogel, R J Noelle
Jun 3, 1999·Proceedings of the Association of American Physicians·A N Theofilopoulos, D H Kono
Jun 8, 1999·Annual Review of Immunology·Y X Fu, D D Chaplin
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Aug 10, 2000·Nature Cell Biology
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J ZhangT Zhou
Mar 13, 2001·Annual Review of Immunology·M Feldmann, R N Maini
Mar 13, 2001·Annual Review of Immunology·B Salomon, J A Bluestone
May 9, 2001·Nature·A J McAdamA H Sharpe
May 19, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·J D Mountz
Feb 2, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiaobo WangAnne Davidson
Apr 26, 2002·Current Opinion in Immunology·Rebecca J GreenwaldArlene H Sharpe
Jul 13, 2002·Arthritis and Rheumatism·Weiqing HuangAnne Davidson
Aug 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhinan YinJoe Craft

❮ Previous
Next ❯

Citations

Jun 8, 2012·Nature Medicine·Zheng Liu, Anne Davidson
Jul 29, 2009·The Journal of Experimental Medicine·Alexander EspinosaMarie Wahren-Herlenius
May 28, 2010·Stem Cell Research & Therapy·Takayoshi YamazaSongtao Shi
Nov 19, 2013·Cellular & Molecular Immunology·Cristen B ChafinChristopher M Reilly
Jun 5, 2013·Nutrition Reviews·Philip B BusbeePrakash S Nagarkatti
Oct 8, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Leilani L Santos, Eric F Morand
Sep 6, 2012·European Journal of Immunology·Aurélie AmbrosiMarie Wahren-Herlenius
Mar 13, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Xiao-Jie YanNicholas Chiorazzi
Mar 2, 2010·Prostaglandins, Leukotrienes, and Essential Fatty Acids·James J Pestka
Mar 23, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Nasrin AsgariAnne Voss
Dec 30, 2016·Virulence·Bryan M Hancock, Kelly S Doran
Oct 2, 2014·Journal of the American Society of Nephrology : JASN·Tamara K NowlingLeah J Siskind
Feb 13, 2010·Expert Opinion on Therapeutic Targets·Dorothee GrevenRichard Bucala
Jun 23, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Celine C BerthierMatthias Kretzler
Jan 1, 2014·Journal of Immunology Research·Guang-ping RuanXing-hua Pan
Nov 21, 2018·Proceedings of the National Academy of Sciences of the United States of America·Maria TokuyamaAkiko Iwasaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
C BanotaiJames J Pestka
Current Opinion in Rheumatology
Vasileios C KyttarisGeorge C Tsokos
© 2021 Meta ULC. All rights reserved